カテゴリー： Transparency Market Research

子宮頸部異形成の世界市場：パップテスト、HPVテスト、生検、コルポスコーピー（膣鏡検査）

【英語タイトル】Cervical Dysplasia Market (Diagnostics - Diagnostic Tests (Pap Smear Test, HPV Test, Biopsy), Diagnostic Devices (Colposcopy); End User - Hospitals, Diagnostic Centers, Private Gynecologists’ Offices, Research and Academic Institutes, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Transparency Market Researchが出版した調査資料（TMR61214）・商品コード：TMR61214
・発行会社（調査会社）：Transparency Market Research
・発行日：2016年11月7日
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,795 ⇒換算￥602,680見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算￥914,680見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算￥1,226,680見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
当調査レポートでは、子宮頸部異形成の世界市場について調査・分析し、産業分析、子宮頸部異形成の世界市場規模、市場シェア、成長、市場動向、予測データを含め、以下の構成でお届けいたします。
・子宮頸部異形成の世界市場：序文
・子宮頸部異形成の世界市場：エグゼクティブサマリー
・子宮頸部異形成の世界市場：市場概要・動向
・子宮頸部異形成の世界市場：セグメント別市場規模・分析
・子宮頸部異形成の世界市場：地域別市場規模・分析
・子宮頸部異形成の世界市場：関連企業分析
【レポートの概要】

Global Cervical Dysplasia Market: Scope and Methodology
This report on the global cervical dysplasia market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global cervical dysplasia market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cervical cancer market.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Cervical Dysplasia Market: Segmentation
Based on the diagnosis, the market has been further segmented into two major segments namely, diagnosis tests and diagnostic devices. Diagnosis segment further sub-segmented into Pap smear test, HPV test, and Biopsy. Moreover, colposcope devices are considered as diagnostic devices for cervical dysplasia market in this report. Based on end user, the market has been segmented into hospitals, diagnostic centers, private gynecological offices, research & academic institutes and ambulatory surgical centers.
Cervical Dysplasia Market: Geographical and Competitive Dynamics
Geographically, the global cervical dysplasia market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.
The report also profiles major players in the cervical dysplasia market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include F. Hoffmann La-Roche Ltd., QIAGEN, Becton, Dickinson and company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., and Abbott Healthcare Pvt Ltd, exhibit the largest geographical outreach with presence in cervical dysplasia product categories.
The global cervical dysplasia market is segmented as follows:
Global Cervical Dysplasia Market Revenue, by Diagnosis
• Diagnosis Test
o Pap Smear Test
o HPV Test
o Biopsy
• Diagnostic Device
o Colposcopy
Global Cervical Dysplasia Market Revenue, by End User
• Hospitals
• Diagnostic Centers
• Private Gynecologists’ Offices
• Research & Academic Institutes
• Ambulatory Surgical Centers
Global Cervical Dysplsia Market, by Geography
• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Rest of Latin America
• Middle East & Africa
o Saudi Arabia
o UAE
o Rest of Middle East & Africa

【レポートの目次】

Section – 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section – 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Cervical Dysplasia: Market Snapshot
3.2 Global Cervical Dysplasia Market: Opportunity Map

Section-4 Market Overview
4.1 Global Cervical Dysplasia Market: Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.2.1 Increasing cervical screening programs
5.1.2.2 Rising Prevalence of Cervical Cancer in aging population
5.1.2.3 Government Funding On Cancer Screening Programs
5.1.2.4 Favorable Government policies
5.1.2.5 Awareness campaigns
5.1.2.6 Increasing Cigarette Smokers around the Globe
5.1.2.7 Government organization recommendations
5.1.3 Restraints
5.1.3.1 Low awareness in underdeveloped countries hinders the growth of the market
5.1.3.2 HPV vaccination recommendations
5.1.3.3 Changes in Government Policies
5.2 Global Cervical Dysplasia Market Revenue Projection
5.3 Porter’s Five Forces Analysis
5.4 Cervical Dysplasia Market Outlook

Section-6 Cervical Dysplasia Market Analysis, By Diagnosis
6.1 Key Findings
6.2 Introduction
6.3 Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type
6.4 Global Cervical Dysplasia Market Forecast, By Diagnosis Type
6.4.1 Diagnostic Test
6.4.1.1. HPV Test
6.4.1.2. Pap Smear Test
6.4.1.3. Biopsy
6.4.2 Diagnostic Devcie
6.4.2.1. Colposcopy
6.5 Global Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type

Section-7 Global Cervical Dysplasia Market Analysis, By End User
7.1 Key Findings
7.2 Introduction
7.3 Global Cervical Dysplasia Market Value Share Analysis, By End User
7.4 Global Cervical Dysplasia Market Forecast, By End User
7.4.1 Hospitals
7.4.2 Diagnostic Centers
7.4.3 Ambulatory Surgical Centers
7.4.4 Private Gynecologist’s Offices
7.4.5 Research & Academic institutes
7.5 Global Cervical Dysplasia Market Attractiveness Analysis, By End User

Section-8 North America Cervical Dysplasia Market Analysis
8.1 Key Findings
8.2 North America Cervical Dysplasia Market Overview
8.3 North America Market Value Share Analysis, By Diagnosis Type
8.3.1 North America Market Forecast, By Diagnosis Type
8.4 North America Market Value Share Analysis, By End User
8.4.1 North America Market Forecast, By End User
8.5 North America Market Forecast, By Country
8.6 North America Market Attractiveness Analysis
8.7 North America Market Trends

Section-9 Europe Cervical Dysplasia Market Analysis
9.1 Key Findings
9.2 Europe Cervical Dysplasia Market Overview
9.3 Europe Market Value Share Analysis, By Diagnosis Type
9.3.1 Europe Market Forecast, By Diagnosis Type
9.4 Europe Market Value Share Analysis, By End User
9.4.1 Europe Market Forecast, By End User
9.5 Europe Market Forecast, By Country
9.6 Europe Market Attractiveness Analysis
9.7 Europe Market Trends

Section-10 Asia Pacific Cervical Dysplasia Market Analysis
10.1 Key Findings
10.2 Asia Pacific Cervical Dysplasia Market Overview
10.3 Asia Pacific Market Value Share Analysis, By Diagnosis Type
10.3.1 Asia Pacific Market Forecast, By Diagnosis Type
10.4 Asia Pacific Market Value Share Analysis, By End User
10.4.1 Asia Pacific Market Forecast, By End User
10.5 Asia Pacific Market Forecast, By Country
10.6 Asia Pacific Market Attractiveness Analysis
10.7 Asia Pacific Market Trends

Section-11 Latin America Cervical Dysplasia Market Analysis
11.1 Key Findings
11.2 Latin America Cervical Dysplasia Market Overview
11.3 Latin America Market Value Share Analysis, By Diagnosis Type
11.3.1 Latin America Market Forecast, By Diagnosis Type
11.4 Latin America Market Value Share Analysis, By End User
11.4.1 Latin America Market Forecast, By End User
11.5 Latin America Market Forecast, By Country
11.6 Latin America Market Attractiveness Analysis
11.7 Latin America Market Trends

Section-12 Middle East and Africa Cervical Dysplasia Market Analysis
12.1 Key Findings
12.2 Middle East and Africa Market Overview
12.3 Middle East and Africa Market Value Share Analysis, By Diagnosis Type
12.3.1 Middle East and Africa Market Forecast, By Diagnosis Type
12.4 Middle East and Africa Market Value Share Analysis, By End User
12.4.1 Middle East and Africa Market Forecast, By End User
12.5 Middle East and Africa Market Forecast, By Country
12.6 Middle East and Africa Market Attractiveness Analysis

Section-13 Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. Becton, Dickinson and company.
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Diagnosis Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2 Hologic, Inc
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Diagnosis Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3 Micromedic Technologies Ltd.
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Diagnosis Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4 OncoHealth Corporation
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Diagnosis Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5 Quest Diagnostics, Inc
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Diagnosis Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6 F. Hoffmann La-Roche Ltd.
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Diagnosis Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7 QIAGEN N.V.
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Diagnosis Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8 Abbott Laboratories
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Diagnosis Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview

List of Figures

Figure01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure02: Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure03: Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type
Figure04: Global Cervical Dysplasia Market Value Share Analysis, by End-user, 2016 and 2024
Figure05: Cervical Dysplasia Market Attractiveness Analysis, by End-user
Figure06: Global Cervical Dysplasia Market Value Share Analysis, by Region, 2016 and 2024
Figure07: Cervical Dysplasia Market Attractiveness Analysis, by Region
Figure09: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure10: North America Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure11: North America Market Attractiveness Analysis, by Country
Figure12: North America Market Value Share Analysis, by Diagnosis Type, 2016 and 2024
Figure13: North America Market Value Share Analysis, by End-User, 2016 and 2024
Figure14: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure15: North America Market Attractiveness Analysis, by Diagnosis Type
Figure16: North America Market Attractiveness Analysis, by End-user
Figure17: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure21: Europe Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure22: Europe Market Attractiveness Analysis, By Country
Figure23: Europe Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure24: Europe Market Value Share Analysis, By End User, 2016 and 2024
Figure25: Europe Market Value Share Analysis, By Country, 2016 and 2024
Figure26: Europe Market Attractiveness Analysis, by Diagnosis
Figure27: Europe Market Attractiveness Analysis, by End User
Figure28: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) and Forecast, 2015–2024
Figure29: Asia Pacific Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure30: Asia Pacific Market Attractiveness Analysis, By Country
Figure31: Asia Pacific Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure32: Asia Pacific Market Value Share Analysis, By End User, 2016 and 2024
Figure33: Asia Pacific Market Value Share Analysis, By Country, 2016 and 2024
Figure34: Asia Pacific Market Attractiveness Analysis, by Diagnosis
Figure35: Asia Pacific Market Attractiveness Analysis, by End User
Figure36: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure37: Latin America Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure38: Latin America Market Attractiveness Analysis, By Country
Figure39: Latin America Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure40: Latin America Market Value Share Analysis, By End User, 2016 and 2024
Figure41: Latin America Market Value Share Analysis, By Country, 2016 and 2024
Figure42: Latin America Market Attractiveness Analysis, by Diagnosis
Figure43: Latin America Market Attractiveness Analysis, by End User
Figure44: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure45: Middle East and Africa Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure46: Middle East and Africa Market Attractiveness Analysis, By Country
Figure47: Middle East and Africa Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure48: Middle East and Africa Market Value Share Analysis, By End User, 2016 and 2024
Figure49: Middle East and Africa Market Value Share Analysis, By Country, 2016 and 2024
Figure50: Middle East and Africa Market Attractiveness Analysis, by Diagnosis
Figure51: Middle East and Africa Market Attractiveness Analysis, by End User

List of Tables

Table 01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 02: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 03: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by Region, 2015–2024
Table 04: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Diagnosis Type, 2015–2024
Table 05: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2015–2024
Table 06: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Country, 2015–2024
Table 07: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 08: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 09: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 10: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 11: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 12: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 13: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 14: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 16: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024



【レポートのキーワード】

子宮頸部異形成、パップテスト、HPVテスト、生検、コルポスコーピー、膣鏡検査

★調査レポート[子宮頸部異形成の世界市場：パップテスト、HPVテスト、生検、コルポスコーピー（膣鏡検査）] (コード：TMR61214)販売に関する免責事項を必ずご確認ください。
★調査レポート[子宮頸部異形成の世界市場：パップテスト、HPVテスト、生検、コルポスコーピー（膣鏡検査）]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆